Protalix BioTherapeutics, Inc.

PLX · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$13,647$17,895$19,458$19,760
Short-Term Investments$15,723$15,503$15,285$15,070
Receivables$14,425$9,443$4,675$2,909
Inventory$21,255$21,131$19,506$21,243
Other Curr. Assets$1,452$1,513$1,590$1,096
Total Curr. Assets$66,502$65,485$60,514$60,078
Property Plant & Equip (Net)$12,534$9,743$9,950$10,021
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$2,679$2,738$2,969$2,856
Other NC Assets$549$520$459$462
Total NC Assets$15,762$13,001$13,378$13,339
Other Assets$0$0$0$0
Total Assets$82,264$78,486$73,892$73,417
Liabilities
Payables$5,375$6,689$4,121$4,533
Short-Term Debt$1,397$1,472$1,425$1,500
Tax Payable$0$3,742$0$3,476
Deferred Revenue$0$0$2,000$0
Other Curr. Liab.$15,173$12,188$16,776$16,112
Total Curr. Liab.$21,945$24,091$24,322$25,621
LT Debt$6,780$3,877$3,811$4,026
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$631$615$551$559
Total NC Liab.$7,411$4,492$4,362$4,585
Other Liabilities$0$0$0$0
Cap. Leases$6,780$5,349$5,236$5,526
Total Liabilities$29,356$28,583$28,684$30,206
Equity
Pref Stock$0$0$0$0
Common Stock$0$80$78$76
Retained Earnings$0-$381,848-$382,012-$378,393
AOCI$0$0$0$0
Other Equity$52,908$431,671$427,142$421,528
Total Equity$52,908$49,903$45,208$43,211
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$82,264$78,486$73,892$73,417
Net Debt-$5,470-$12,546-$14,222-$14,234